Global Epidural Anesthesia Needles market size is USD 1,595.2 million in 2024.

According to Cognitive Market Research, the global Epidural Anesthesia Needles market size is USD 1,595.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 9.00% from 2024 to 2031.North America held the major market of more than 40% of the global revenue with a market size of USD 638.08 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2031.Europe accounted for a share of over 30% of the global market size of USD 478.56 million.Asia Pacific held the market of around 23% of the global revenue with a market size of USD 366.90 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031.Latin America market of more than 5% of the global revenue with a market size of USD 79.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.Middle East and Africa held the major market of around 2% of the global revenue with a market size of USD 31.90 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.7% from 2024 to 2031.Adults segment is the predominant segment in the Epidural Anesthesia Needles market. Market Dynamics of Epidural Anesthesia Needles MarketKey Drivers for Epidural Anesthesia Needles MarketIncrease in aging population fuels the epidural anesthesia needles marketThe aging population causes an increase in procedures, which drives the epidural anesthetic needle market. Growing life expectancy, combined with age-related comorbidities, has led in an increase in the number of older people undergoing surgery. The prevalence of cardiovascular illness, arthritis, thyroid disease, and emphysema is gradually increasing, resulting in a proportional increase in the number of procedures along with disease prevalence. These diseases primarily affect the elderly, which is raising the need for anesthetic disposables, which are commonly used in surgical procedures and will drive the market over the projection period.Increasing prevalence of chronic pain Propel Market GrowthThe increasing prevalence of chronic pain is a key driver of the demand for epidural anesthesia needles. Persistent pain that lasts for three months or longer is classified as chronic. Back pain, arthritis, and cancer-related pain are becoming increasingly common, highlighting the need for more important pain management options. Needles are often utilized for epidural anesthesia to alleviate specific pain in pain management treatments. By injecting medicine directly into the epidural region, medical professionals can numb nerves and relieve pain with these needles. This will drive the market for epidural anesthetic needles forward as the number of persons with persistent pain increases.Restraint Factor for the Epidural Anesthesia Needles MarketShortage of skilled anesthesiologists is limiting the marketAnesthetists perform a critical role in patients' care during and after surgery or procedure. They gain the ability to provide a higher quality of care to their patients. As the number of patients, particularly those undergoing surgery and operations, rises worldwide, so does the demand for experienced and trained anesthetists. To satisfy increased patient demand for anesthesia services, countries are experiencing a significant scarcity of experienced and trained anesthetists. For instance, the Centre for Workforce Intelligence, a unit of UK NHS staffing agency Health Education England, indicated that their analysis predicted that demand for anesthetic services will increase by 25% by 2033, requiring an additional 300 anesthetists per year. According to a research undertaken by the American Association of Medical Colleges (AAMC), a 33,800 to 72,700 physician shortage across specialties is projected by 2031.Impact of Covid-19 on the Epidural Anesthesia Needles MarketThe COVID-19 epidemic has had a considerable impact on the use of epidural anesthesia needle. Because the virus is extremely contagious, healthcare staff are at a higher risk of exposure when performing intubations on COVID-19 patients. As a result, this product has become increasingly widely used to lower the danger of virus transmission. The medicine has proven particularly effective in controlling problematic airways in COVID-19 patients who are in severe respiratory distress or require continuous mechanical ventilation. The video display enables the anesthesiologist to...